Within the list of significantly DE genes, interferon-induced transmembrane protein 2 (IFITM2), FAM65B and SELL were downregulated in all ILC subsets in COVID-19 patients compared with healthy controls (Figures 2C, D). This evidence concerns the gene IFITM2 and COVID-19.